A Partnership of ABC and CRF

Facebook Live

Diabetes rates are rising. Now more than ever, it’s critically important for cardiologists to take an active role in cardiometabolic risk reduction and the treatment of diabetes. Watch this program to learn more about current treatment options for cardiovascular risk reduction in patients with diabetes.

This program was supported by AstraZeneca and Boehringer Ingelheim.